Clinical trial
An Observational Study of Patients With Moderate Parkinson's Disease
NCT05779475 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patients With Moderate Parkinson's Disease
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 5, 2023
- Completion date
- March 11, 2030
- Enrollment
- 96 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.